V001-6626 Screening compound: 1-[2-(4-chlorophenyl)-2-{[4-(trifluoromethyl)phenyl]methoxy}ethyl]-4-[3-(2-chlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]piperazine

V001-6626 Screening compound: 1-[2-(4-chlorophenyl)-2-{[4-(trifluoromethyl)phenyl]methoxy}ethyl]-4-[3-(2-chlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]piperazine
V001-6626 Screening compound: 1-[2-(4-chlorophenyl)-2-{[4-(trifluoromethyl)phenyl]methoxy}ethyl]-4-[3-(2-chlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]piperazine alternative view

Chemical Structure Depiction of ChemDiv screening compound V001-6626
1-[2-(4-chlorophenyl)-2-{[4-(trifluoromethyl)phenyl]methoxy}ethyl]-4-[3-(2-chlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]piperazine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V001-6626

Molecular Formula

C31H28Cl2F3N3O3 (C31 H28 Cl2 F3 N3 O3)

Compound Name

1-[2-(4-chlorophenyl)-2-{[4-(trifluoromethyl)phenyl]methoxy}ethyl]-4-[3-(2-chlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]piperazine

IUPAC name

1-[2-(4-chlorophenyl)-2-{[4-(trifluoromethyl)phenyl]methoxy}ethyl]-4-[3-(2-chlorophenyl)-5-methyl-12-oxazole-4-carbonyl]piperazine

SMILES

Cc1c(C(N2CCN(CC(c(cc3)ccc3Cl)OCc3ccc(C(F)(F)F)cc3)CC2)=O)c(-c(cccc2)c2Cl)no1

InChI

InChI=1S/C31H28Cl2F3N3O3/c1-20-28(29(37-42-20)25-4-2-3-5-26(25)33)30(40)39-16-14-38(15-17-39)18-27(22-8-12-24(32)13-9-22)41-19-21-6-10-23(11-7-21)31(34,35)36/h2-13,27H,14-19H2,1H3/t27-/m0/s1

InChI Key

RIXWHJIUQGVYQZ-MHZLTWQESA-N

MDL Number (MFCD)

MFCD19954693

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

618.48

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

6.296

Distribution Coefficient, logD

6.293

Water Solubility, LogSw

-6.15

Polar Surface Area

49.268

Acid Dissociation Constant (pKa)

23.09

Base Dissociation Constant (pKb)

5.20

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

29.00

V001-6626 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Nervous system
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
Targets:
  • GPCR
  • GPCR
  • Ion Channels
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V001-6626 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V001-6626?
Check Price and Availability of V001-6626, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V001-6626 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V001-6626
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V001-6626
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V001-6626 available by request